Subscribe


PD breaking news – ACCC to appeal atorvastatin decision

Federal Court dismissed anti-competitive conduct case in February. 

The Australian Competition and Consumer Commission (ACCC) has filed a Notice to Appeal for the Federal Court’s decision to dismiss its anti-competitive conduct case against Pfizer.

The ACCC allegations related to offers made to pharmacies in early 2012 for the supply of Lipitor and Pfizer’s generic atorvastatin product, with the ACCC alleging Pfizer had misused its “substantial market power” and engaged in exclusive dealing conduct for the purpose of substantially lessening competition.

The Federal Court dismissed the case, saying that while Pfizer had taken advantage of its market power with the alleged conduct, this power was no longer substantial at the time of the offers, and that the ACCC had not established that Pfizer had engaged in this conduct to deter or prevent competitive conduct (PD 26 Feb).

ACCC chairman Rod Sims said cases involving allegations of misuse of market power and anti-competitive practices would always be a priority for the organisation.

“It is therefore important that the ACCC seeks clarity from the Full Court on issues of market power and anti-competitive purpose, such as those raised by this case.”

For more, see tomorrow’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 18 Mar 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

23 Jan

Guild Update 23 Jan 18 - WITH just over a week to go ...


23 Jan

Dispensary Corner 23 Jan 18 - KEEPING kids who suffer from conditions such ...


23 Jan

NZSMI blasts NZ codeine upschedule - ...


23 Jan

Pharmacy BP clinics - THE role community pharmacies can play in ...


23 Jan

Zantac discount deal - ASPEN Australia is promoting a special "double ...


23 Jan

Not-so-smart thief - A woman has been sentenced in the ...


23 Jan

February epidemic asthma surge - THE National Asthma Council Australia is urging ...


23 Jan

New GSK APAC chief - GSK Consumer Healthcare has appointed Filippo Lanzi ...


23 Jan

Pharmacists and AMR - PHARMACISTS are an "underutilised resource for Antimicrobial ...


23 Jan

Adherence Perx - SYDNEY start-up Perx Health, with the support ...


23 Jan

FDA recall guidance - THE U.S. Food and Drug Administration (FDA) ...


23 Jan

TGA extends tender - THE TGA has extended the lodgement date ...


23 Jan

CMA blasts ‘fringe’ groups - COMPLEMENTARY Medicines Australia (CMA) has criticised Friends ...


23 Jan

Dose Innovations administration - EXTERNAL administrators have been appointed to Brisbane-based ...


22 Jan

Weekly Comment 22 Jan 18 - WELCOME to PD's weekly comment feature. This ...


22 Jan

Dispensary Corner 22 Jan 18 - MEDICINAL marijuana is the subject of several ...


22 Jan

FDA pings Delta Labs - THE US Food and Drug Administration (FDA) ...


22 Jan

S3 ad clarification - THE Therapeutic Goods Administration has stressed that ...


22 Jan

Opioid consultation - OPTIONS for a regulatory response to opioid ...


22 Jan

Metformin recall - APOTEX is recallilng one patch of APO-Metformin ...



Show Pharmacy Daily items by month: